Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: fyi...the initial rejection of the 148 has been reversed..buying time IMO

when citing prior art??

looks like he's comparing to different "processes"

Joseph P. is familiar with our patents as it was HE who first approved some/all??? of the MMP the first time around.

So why throw out Kajigaya? I "get" the "leave no stone unturned" but shouldn't the prior art be somewhat related to our invention?

At this point in the game, I would imagine that TPL/Chuck Moore are ready to sit down and "teach" the USPTO examiner the differences............but shouldn't he KNOW this by now??

seems like a waste of time. step by step.......INCH BY INCH.

we'll get there IMO.

SP is sickening, but this is a complicated process and for those not reading daily and doing there own side DD, it's pretty confusing and scary but we are NOT dead in the water by any means.

This second non final action is pretty standard in the review process and hopefully will be the LAST one.

d

Share
New Message
Please login to post a reply